Benoit Christian Mouzon, PhD
Research Biologist
Benoit.Mouzon@va.gov
Bmouzon@roskampinstitute.org
Affiliation(s)
The Roskamp Institute
Scientist II
Research
Research Area(s): Traumatic brain injury; Traumatic optic neuropathy; Inflammation; Toxic exposure
Research Population: Brain injured patients; Gulf War/Vietnam Veteran patients; Patients exposed to any type of toxic exposure; Patients with visual dysfunction
Research Methods: Neuropathology; Neurobehavior; Biochemistry and plasma Biomarkers; Brain Imaging
Collaboration
Dr. Mouzon is Interested in collaborating with any scientist working in his field of study, including TBI, neurodegeneration, visual dysfunction, toxic exposure, gastrointestinal disorders, and aging neuroinflammation (or any other diseases). He has blood and plasma samples that remain unused from his studies, which he is happy to share with researchers who can utilize them for their work. Additionally, he can collect tissue samples and provide organs to anyone interested in conducting relevant analyses. Dr. Mouzon believe that by fostering these collaborations, researchers can maximize the impact of their research and ensure the most effective use of the animals in their studies. Furthermore, he encourages any Veterans who would like to share their story to reach out to him. Veteran experiences are invaluable in advancing research and improving our understanding of the long-term effects of these conditions.
Connect with Dr. Mouzon
Recent Funding History
| Dates | Title | Funding Source and Type | Role |
|---|---|---|---|
| 2023 – 2027 | Amnion cell secretome mediated therapy for traumatic brain injury | VA Merit | PI |
| 2024 – 2028 | Development of ultra-selective DYRK1A inhibitors as a novel therapeutic modality for TBI | DoD PHRP | PI |
| 2022 – 2025 | Altered brain fluid dynamics and solute elimination following repetitive mild traumatic brain injury | DoD PHRP | Co-I |
| 2023 – 2026 | Amnion-Derived Multipotent Cell Secretome-Mediated Therapy for Gulf War Illness | DoD TERP | PI |
| 2023 – 2026 | Amnion cell secretome mediated therapy for traumatic brain injury | DoD PHRP | PI |
| 2019 – 2022 | The Influence of Traumatic Brain Injury on Gulf War Illness Pathogenesis | DoD GWIRP | PI |
| 2021 – 2023 | Amnion cell secretome mediated therapy for Gulf War Illness | DoD GWIRP | PI |
| 2020 – 2022 | Amnion Cell Secretome mediated therapy for the restoration of traumatic optic neuropathy after brain trauma | DoD VRP | PI |
| 2020 – 2022 | Long-term effects of opioid use in a mouse model of repetitive mild traumatic brain injury | VA SpiRE | Multiple PI |
| 2019 – 2021 | Development of Neural Stem Cell mediated therapy for repetitive mild TBI | NIH R03 | PI |